One the other hand, recent evidence obtained in an animal model where deletion of BACE1 was performed at the adult stage to mimic BACE1 inhibition in AD patients, demonstrates that sequential and gradual BACE1 inhibition can completely reverse amyloid pathology. This evidence concerns the gene BACE1 and Alzheimer disease.